News tagged with pharmaceutical companies

Nov 30, 2009 | not rated yet | 0

In BMJ today two experts debate whether the conflict of interest is unacceptable when drug companies carry out clinical trials on their own medicines.

Drug industry presses FDA to allow more online ads

Nov 11, 2009 | not rated yet | 1

(AP) -- As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter ...

Study Suggests Affordable Vaccines Within Reach

Nov 03, 2009 | not rated yet | 0

(PhysOrg.com) -- A new research paper suggests that pharmaceutical companies can afford to produce less expensive vaccines for lower-income countries because the companies can recover their research and development (R&D) ...

Patent challenges reduce pharmaceutical innovation and productivity, researchers suggest

Patent challenges reduce pharmaceutical innovation and productivity, researchers say

Oct 15, 2009 | 3 / 5 (3) | 1

The development of new and innovative pharmaceuticals is being stifled by a U.S. law and successful patent challenges that embolden generic competition, according to an article published in this week's issue ...

Sanofi to deliver swine flu vaccine in October

Sep 21, 2009 | not rated yet | 0

(AP) -- Sanofi-Aventis SA will begin delivering the first doses of its new swine flu vaccine in the United States by mid-October, the head of France's largest pharmaceutical company said Monday.

WHO predicts 'explosion' of swine flu cases

Aug 21, 2009 | not rated yet | 1

(AP) -- The global spread of swine flu will endanger more lives as it speeds up in coming months and governments must boost preparations for a swift response, the World Health Organization said Friday.

Project Zero Delay accelerates drug's path to clinical trial

Medicine & Health / Cancer

Aug 03, 2009 | not rated yet | 0

A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six ...

Human trials of swine flu drug start in Australia (AP)

Australia starts 1st swine flu vaccine trials

Jul 22, 2009 | 3 / 5 (2) | 0

(AP) -- The world's first human trials of a swine flu vaccine have begun in Australia, drug company officials said Wednesday, with the aim of controlling the virus that has so far killed more than 700 worldwide.

Fight for swine flu vaccine could get ugly

Jul 16, 2009 | 1.8 / 5 (5) | 4

(AP) -- An ugly scramble is brewing over the swine flu vaccine - and when it becomes available, Britain, the United States and other nations could find that the contracts they signed with pharmaceutical companies are easily ...

WHO: No swine flu vaccine available for months (AP)

WHO: No swine flu vaccine available for months (Update)

May 19, 2009 | 1 / 5 (1) | 0

(AP) -- Drug manufacturers won't be able to start making a swine flu vaccine until mid-July at the earliest, weeks later than previous predictions, the World Health Organization said Tuesday. It will then ...

WHO eyes swine flu transmision rates, new vaccine

May 17, 2009 | 1 / 5 (1) | 0

(AP) -- Health experts are looking very closely at the spread of swine flu among people in Spain, Britain and Japan, a WHO official said Sunday as Japan reported a one-day explosion of over 70 new cases, ...

New fund promises low-cost malaria treatment

Apr 19, 2009 | 5 / 5 (1) | 0

(AP) -- A $225 million fund to provide low-price anti-malaria medicine around the world was launched in the Norwegian capital Friday to fight a disease that kills 2,000 children a day.

Nurse practitioners don't realise how much their prescribing is being influenced by drug marketing

Mar 10, 2009 | not rated yet | 0

Family nurse practitioners need to be more aware of the commercial pressures they face as a result of their increased involvement in prescribing, according to a survey published in the March issue of the UK-based Journal of ...

Researchers: Strengthen restrictions on off-label promotion by pharmaceutical companies